Related by context. All words. (Click for frequent words.) 71 kidney urologic 70 Evoltra ® 70 PLX MS 70 hormone gastrin 70 SNT MC# 70 receptor tyrosine kinase inhibitor 69 PDE# inhibitors 69 Nanobody ® 69 immunological diseases 69 therapeutic monoclonal antibody 69 HuLuc# 69 A3 adenosine receptor 69 Virulizin ® 69 Ceflatonin 69 CEQ# 69 monoclonal antibody therapeutics 69 thetreatment 68 RNAi therapeutic targeting 68 OMAPRO 68 IMA# 68 VitiGam 68 Aviptadil 68 CCX# 68 targeted radiotherapeutic 68 biologic therapeutics 68 Squalamine 68 OHR/AVR# 68 Azedra 68 cMET 68 MAGE A3 ASCI 68 FOLOTYN ® 68 tranilast 68 Archexin 68 anticancer therapies 68 Nanobody 68 JAK inhibitors 68 BRAF inhibitor 68 Pertuzumab 68 Factor VIIa 68 Gleevec resistant 67 thalidomide Thalomid 67 MEK inhibitors 67 therapeutic peptide 67 ALN PCS 67 predictive biomarkers 67 Vandetanib 67 JAK2 inhibitor 67 HGS# 67 forodesine 67 CYT# potent vascular disrupting 67 Therapeutic antibodies 67 epigenetic therapies 67 dasatinib Sprycel 67 EndoTAG TM 67 MOZOBIL 67 NP2 Enkephalin 67 ospemifene 67 anti angiogenic agents 67 p# inhibitor 67 pertuzumab 67 YONDELIS 67 therapeutic monoclonal antibodies 67 lumiliximab 67 ZACTIMA 67 multi kinase inhibitor 67 Insegia 67 NNR Therapeutics 67 hematological indications 67 Panzem 67 BRAF inhibitors 67 molecular biomarkers 67 Phase IIb clinical trials 67 histone deacetylase HDAC 67 CB1 antagonists 67 PI3K/mTOR 67 novel peptide 67 Cancidas 67 regorafenib 67 Pirfenidone 67 LHRH antagonists 67 lapatinib Tykerb 67 AEG# 67 ixabepilone 66 neovascular diseases 66 VitiGam TM 66 siRNA therapeutics 66 ischemic tissues 66 neuronal nicotinic receptors NNRs 66 Panzem R 66 Degarelix 66 novel therapeutic antibodies 66 Velcade bortezomib 66 acyclovir Lauriad R 66 immunotherapeutic vaccine 66 rxRNA 66 Golimumab 66 vemurafenib 66 ENMD # 66 PhG alpha 1 66 Nexavar sorafenib 66 IMC #B 66 investigational humanized monoclonal antibody 66 proteasome inhibitor 66 ASPIRE HIGHER 66 anticancer therapeutics 66 phase IIa clinical 66 BCR ABL inhibitors 66 monoclonal antibody MAb 66 Hepatocellular Carcinoma HCC 66 cardio renal 66 vidofludimus 66 registrational 66 prostate cancer antigen prostatic 66 diagnostic biomarkers 66 antisense inhibitors 66 interventional therapies 66 sunitinib malate 66 immune modulating 66 NovaBay Aganocide compounds 66 GRN# 66 Triapine 66 peptibody 66 Omacetaxine 66 Tyrima 66 acetonide FA 66 Multiferon ® 66 ATL# [001] 66 Zybrestat 66 Pyridorin 66 treating neuropathic pain 66 renin inhibitors 66 Proxinium TM 66 immunomodulatory therapy 66 IL# PE#QQR 66 Panzem R NCD 66 PEG SN# 66 torezolid phosphate 66 Campath alemtuzumab 66 INCB# [001] 66 CINTREDEKIN BESUDOTOX 66 SinuNase ™ 66 Cloretazine 66 anti angiogenic drugs 66 THR beta agonist 66 Alzhemed TM 66 eTag assays 66 humanised monoclonal antibody 66 Personalized Immunotherapy 66 vascular disrupting agents 66 histone deacetylase inhibitor 66 Tesmilifene 66 OvaRex ® MAb 66 Actimmune ® 66 systemic RNAi therapeutic 66 obatoclax 66 PI3K/Akt pathway inhibitor 66 trastuzumab DM1 65 PNP inhibitor 65 BHT DNA 65 theranostics 65 GED aPC 65 AMPK activators 65 M2 subunit 65 novel oral anticoagulant 65 isoform selective 65 mTOR inhibition 65 haematological cancers 65 BrachySil TM 65 EndoTAG TM -1 65 myeloproliferative disorders 65 IAP inhibitors 65 GAP #B# 65 multiple myeloma MM 65 CCR9 antagonist 65 radionuclide therapy 65 PDE4 inhibitor 65 DPX Survivac 65 alefacept 65 riociguat 65 Trofex 65 Vidaza azacitidine 65 Sudhir Agrawal D.Phil 65 refractory metastatic 65 Zemplar Capsules 65 HCV protease inhibitors 65 chemically modified siRNA 65 cancer immunotherapies 65 DU #b 65 IAP inhibitor 65 Factor Xa inhibitor 65 EGS# 65 systemic immunosuppressive drugs 65 DCVax R 65 PI3K inhibitors 65 oral taxane 65 tyrosine kinase inhibitor TKI 65 galiximab 65 Cloretazine R 65 EGFR pathway 65 gefitinib Iressa 65 JAK3 65 ALN HTT 65 midstage trials 65 Davanat 65 GW# [003] 65 enzastaurin 65 fusion enhancers 65 HQK 65 ALN TTR 65 tezampanel 65 DXL# 65 Icatibant 65 phase IIb trial 65 Firazyr 65 PROCHYMAL 65 Immunotherapeutic 65 Deforolimus 65 CINOD 65 Hepatitis C HCV 65 tiapamil 65 systemic fungal infections 65 Nanobodies ® 65 pediatric acute lymphoblastic 65 oxypurinol 65 tubulin inhibitor 65 MAXY G# 65 mTOR inhibitors 65 constipation OIC 65 IRX 2 65 Enzastaurin 65 Noxafil 65 Campath ® 65 OMNARIS HFA 65 THALOMID 65 Soliris eculizumab 65 renin inhibition 65 immunotherapeutic approaches 65 PRT# 65 protein kinase inhibitor 65 OncoVex 65 BCR ABL inhibitor 65 SERMs 65 eritoran 65 OncoVEX 65 Orencia abatacept 65 radiolabeled TM# 65 Solazed 65 deforolimus 65 Exelixis XL# 65 Onconase 65 Xanafide 65 HCD# [002] 65 pomalidomide 65 Troxatyl 65 CA4P 65 MGd 65 Sutent sunitinib 65 Gleevec imatinib 65 Cimzia TM 65 NV1FGF 65 Cardio Vascu Grow 65 protein kinase inhibitors 65 therapeutic regimens 65 histone deacetylase HDAC inhibitor 65 CytoFab ™ 65 Allovectin 7 R 65 LNP formulations 65 ganaxolone 65 AAG geldanamycin analog 65 TBC# 64 Rilonacept 64 GLPG# 64 ZOLINZA 64 cilengitide 64 reslizumab 64 myelofibrosis polycythemia vera 64 NTDDS 64 Abiraterone 64 novel peptides 64 Hsp# inhibition 64 personalized immunotherapy 64 cystinosis patients 64 DPP4 64 Solazed TM 64 Myocet 64 Amrubicin 64 oral prodrug 64 Carfilzomib 64 biologic therapies 64 neratinib 64 psoriasis rheumatoid arthritis 64 elotuzumab 64 PHX# 64 Tykerb lapatinib 64 targeted antifolate 64 TG# [003] 64 SUTENT ® 64 Evoltra 64 Talabostat 64 StemEx R 64 Annamycin 64 IgG1 monoclonal antibody 64 velafermin 64 lintuzumab SGN 64 ponatinib 64 Tarmogen 64 P#X# antagonist 64 Nanobody R 64 PORxin TM 64 Phase #b/#a clinical 64 delta isoform 64 Symadex 64 Cx# [002] 64 clevidipine 64 OMP #M# 64 CR# vcMMAE 64 CINQUIL 64 novel immunotherapies 64 Erbitux cetuximab 64 RIGScan CR 64 Tarceva TM 64 volociximab 64 midstage studies 64 Zenvia ™ 64 orally administered inhibitor 64 depsipeptide 64 Angiocept 64 Bezielle 64 IMiDs 64 aerosolized KL4 surfactant 64 Zemiva TM 64 CytoFabTM 64 radiotherapeutic 64 rFactor XIII 64 dexpramipexole 64 antiangiogenesis 64 Pralatrexate 64 VEGF inhibitors 64 targeting CD# 64 Ketotransdel TM 64 Clolar ® 64 acadesine 64 Daclizumab 64 tafamidis 64 Vicinium TM 64 oral picoplatin 64 novel VDA molecule 64 blood clot dissolver 64 EP #R 64 mertansine 64 CTAP# Capsules 64 theranostic 64 noninfectious uveitis 64 oral salmon calcitonin 64 molecularly targeted 64 Afatinib 64 gastro intestinal inflammation 64 ALK inhibitors 64 mda 7 64 immunomodulation 64 endothelin antagonist 64 Stapled Peptide 64 M# rationally 64 rALLy clinical trial 64 lomitapide 64 Urocidin TM 64 AQ4N 64 Poly ICLC 64 TOCOSOL Camptothecin 64 mTOR kinase 64 samalizumab 64 bortezomib Velcade 64 Aplidin 64 sJIA 64 Mipomersen 64 Amplimexon 64 lymphoid malignancies 64 HepDirect technology 64 MyVax ® 64 PLX cells 64 imatinib Gleevec 64 Dalbavancin 64 neuroendocrine cancers 64 immune modulators 64 diarrhea predominant irritable 64 LentiVector technology 64 cediranib 64 Evoltra TM 64 OMP #R# 64 inhibit EGFR 64 candidate CRLX# 64 preclinically 64 ACOMPLIA R 64 OvaRex R 64 Prodarsan ® 64 Microplasmin 64 TTR amyloidosis 64 Litx 64 otelixizumab 64 TLR antagonists 64 cannabinor 64 pain palliation 64 inhibit metastasis 64 SARMs 64 tanespimycin 64 SUTENT 64 candidate TNFerade biologic 64 paclitaxel Taxol ® 64 YONDELIS R 64 Selective Electrochemical Tumor Ablation 64 MEK Inhibitor 64 antibody MAb 64 Corgentin 64 Pazopanib 64 herpetic keratitis 64 LEUKINE 64 EGFR inhibitors 64 anti secretory 64 antiangiogenic drugs 64 Hedgehog inhibitor 64 castrate resistant prostate cancer 64 lucinactant 64 either acutely decompensated 64 oral PTH 64 sorafenib tablets 64 nicotinic alpha 7 64 Stedivaze 64 non alcoholic steatohepatitis 64 Mepact 64 HGS ETR2 64 Blinatumomab 64 ISTODAX 64 adrenergic regulation 64 FVIIa 64 Prodarsan R 64 optimal dosing regimens 64 Generx ™ 63 Octreolin 63 Romidepsin 63 nonclinical studies 63 AT1R 63 ADVEXIN therapy 63 metastatic colorectal 63 HCV polymerase 63 Interferon alpha 63 Genentech Rituxan 63 Liprotamase 63 beta 1a 63 Amigal 63 GI motility disorders 63 Anti angiogenic 63 budesonide foam 63 pralatrexate 63 investigational immunotherapy 63 Temsirolimus 63 Allovectin 7 ® 63 incyclinide 63 refractory CLL 63 biomarker identification 63 diseases fat malabsorption 63 UPLYSO 63 Trandolapril 63 ESBA# 63 Triapine R 63 PLK1 SNALP 63 metastatic neuroendocrine tumors 63 investigational monoclonal antibody 63 eprotirome 63 Vectibix panitumumab 63 bevacizumab Avastin ® 63 Nanobodies R 63 omacetaxine mepesuccinate 63 Triolex 63 Actemra tocilizumab 63 accumulate preferentially 63 PTK# 63 topical formulations 63 OncoVEX GM CSF 63 romidepsin 63 oncology indications 63 cytotoxics 63 nucleoside analog 63 ALGRX 63 Fabry Disease 63 Phylomer ® 63 efficacy tolerability 63 Trofex TM 63 tezampanel NGX# 63 #ME# 63 Gleevec Glivec 63 GVAX cancer 63 Dasatinib 63 liprotamase 63 CD# expressing 63 microtubule inhibitor 63 immuno modulatory 63 Aryplase 63 Fibrillex TM 63 TNF alpha antagonist 63 omacetaxine 63 chemopreventive agents 63 antiproliferative effects 63 Muraglitazar 63 MMP inhibitors 63 trastuzumab Herceptin ® 63 delay bone metastases 63 prokinetic agent 63 refractory APL 63 Modrenal 63 immatics 63 RhuDex ® 63 Pimavanserin 63 Anticalin 63 cardiometabolic disorders 63 signal transduction inhibitors 63 midstage clinical 63 immune modulatory 63 teriflunomide 63 Ixempra 63 EGFR HER 63 prognostic markers 63 Nanobodies 63 Interferon beta 63 TPI ASM8 63 Neuradiab 63 Modrenal R 63 Civacir 63 Shigamabs ® 63 AA amyloidosis 63 efaproxiral 63 novel histone deacetylase 63 Benlysta belimumab 63 DPP4 inhibitor 63 anticancer compound 63 small molecule activators 63 Diamyd ® 63 anti CD# antibodies 63 AMEVIVE 63 TRV# [001] 63 neuroprotective properties 63 secretory diarrhea 63 HyACT 63 DACH platinum 63 TransMID TM 63 Ocrelizumab 63 Omapro 63 p# biomarker 63 oral dnaJP1 63 immunologic diseases 63 Alvesco R 63 ADME properties 63 glatiramer 63 radezolid 63 Src inhibitors 63 anticancer therapy 63 diabetic neuropathic pain 63 polymerase inhibitors 63 Virulizin R 63 HepDirect 63 hypereosinophilic syndrome 63 PDE# 63 EGFR HER2 63 visilizumab 63 pregabalin Lyrica 63 JAK inhibitor 63 RSD# oral 63 CBLC# 63 epithelial tumors 63 ZFP Therapeutics 63 RNAi therapeutic targeting PCSK9 63 talactoferrin 63 sd rxRNA 63 intranasal delivery 63 antiangiogenic agent 63 GAMMAGARD 63 oncolytic virus therapies 63 MT#/MEDI-# 63 mTOR inhibitor 63 hematological cancers 63 THALOMID ® 63 GPCR targets 63 SinuNase TM 63 TLR9 agonist 63 Foradil Aerolizer 63 potent antiproliferative 63 NXL# 63 zanolimumab 63 monoclonal antibody therapies 63 MKC# MT 63 nitric oxide donating prostaglandin 63 anti angiogenic therapy 63 oral deforolimus 63 Arranon 63 vinca alkaloid 63 alvespimycin 63 Tasimelteon 63 severe gastroparesis 63 cyclophilin inhibitor 63 oral kinase inhibitor 63 tyrosine kinase inhibitor 63 BAY #-# 63 cardio metabolic diseases 63 Certican 63 ARIKACE ™ 63 Zorbtive TM 63 CTLA4 Ig 63 metaglidasen 63 Aurexis 63 ganetespib 63 Revimmune TM 63 molecularly targeted therapies 63 Urocidin 63 drug ISA# 63 Genasense ® 63 BiTE 63 adalimumab Humira 63 Removab 63 immunosuppressive regimens 63 Cabazitaxel 63 ALK inhibitor 63 prostone 63 #I TM# 63 sapacitabine CYC# 63 histone deacetylase HDAC inhibitors 63 miglustat 63 adult mesenchymal stem 63 Neulasta ® 63 pancreatic neuroendocrine tumors 63 MAXY VII 63 validating biomarkers 63 Zolinza 63 JAK1 63 motesanib 63 gastrointestinal stromal tumors GISTs 63 Exherin TM 63 multicenter Phase II 63 histamine dihydrochloride 63 TroVax ® 63 irinotecan oxaliplatin 63 molecular imaging radiopharmaceuticals 63 Sapacitabine 63 Cethrin R 63 triphendiol 63 Iluvien ® 63 RLY# 63 ALN VSP 63 oral antiviral 63 PXD# 63 BiovaxID TM 63 oncolytic 63 Angiolix 63 haematologic malignancies 63 SPRYCEL ® 63 ONCASPAR 63 Surfaxin LS 63 chemotherapy induced neutropenia 63 Alferon N 63 Herceptin trastuzumab 63 INTERCEPT platelets 62 Phase Ib II 62 HDL Mimetic Peptide 62 KIACTA ™ 62 lupus nephritis 62 RhuDex TM 62 XmAb# 62 G#DT 62 Enkephalin 62 Zavesca r 62 R sorafenib tablets 62 TOLAMBA 62 siRNA therapeutic 62 HSP# inhibitor 62 diagnostic molecular imaging 62 TACI Ig 62 CDP# 62 BZL# 62 Leukine 62 leukotriene pathway 62 palliative radiotherapy 62 systemic RNAi 62 intracellular signaling pathways 62 glucokinase activator 62 pan HDAC inhibitor 62 Dacogen decitabine 62 generation purine nucleoside 62 hoFH 62 hedgehog pathway 62 Sym# 62 MORAb 62 MKC# MKC# PP 62 genomic biomarker 62 Martin Nicklasson CEO 62 faropenem 62 relapsed MM 62 AGHD 62 Cytolin R 62 cutaneous T 62 docetaxel Taxotere ® 62 ONCONASE R 62 Multiferon R 62 Anturol TM 62 glucagon receptor 62 oxaliplatin Eloxatin 62 immune modulation 62 liposomal formulation 62 Elagolix 62 CAMPATH 62 HIV integrase inhibitors 62 IL-#/# 62 Aflibercept 62 engineered RAP peptides 62 efalizumab 62 Allovectin 7 62 targeting PCSK9 62 GTC recombinant human 62 Combivir Kivexa 62 Alequel TM 62 Aquinox 62 including eniluracil ADH 62 immunomodulatory 62 inhibiting angiogenesis 62 Telatinib 62 liposomal ciprofloxacin 62 Orazol 62 mGluR2 NAM 62 Friedreich Ataxia FRDA 62 Pathway Inhibitor 62 TLR8 agonist 62 Enzyme Replacement Therapy 62 Ampakine compounds 62 humanized monoclonal antibodies 62 prophylactic therapy 62 Novartis Gleevec 62 immunotherapeutics 62 immunodeficiency disorders 62 multiple sclerosis rheumatoid arthritis 62 CD# monoclonal antibody 62 Phase IIIb clinical 62 investigational compounds 62 idiopathic pulmonary fibrosis IPF 62 Cethrin 62 GMX# 62 therapeutics 62 oral JAK1 62 anti fibrotic 62 nilotinib Tasigna 62 Chimigen TM 62 LEP ETU 62 rNAPc2 62 relapsed ovarian cancer 62 HuCNS SC ® 62 Exelixis compounds 62 Pafuramidine 62 GLP toxicology studies 62 MEK inhibitor 62 highly selective inhibitor 62 Celator 62 Elotuzumab 62 pharmacodynamic parameters 62 GRNVAC1 62 Elocalcitol 62 radiation sensitizer 62 HepDirect R 62 ASONEP 62 dextofisopam 62 immuno inflammatory diseases 62 IMiDs ® compound 62 synthetic retinoid 62 OnDose TM 62 opioid induced bowel dysfunction 62 Collategene 62 refractory angina 62 lung pancreatic 62 candidate epratuzumab 62 molecular imaging radiopharmaceutical 62 KRN# 62 nalbuphine ER 62 Poly ICR 62 chemopreventive agent 62 ularitide 62 trastuzumab Herceptin 62 drug GAP #B# 62 Phase Ib study 62 Intravenous CP 62 small molecule tyrosine 62 neuro inflammatory 62 dexanabinol 62 SERCA2a 62 secondary hyperparathyroidism 62 Vidofludimus 62 dirucotide MBP# 62 ALN TTR# 62 immune modulator 62 IMC A# 62 Torisel 62 Catena ® 62 cytotoxic therapies 62 intranasal formulation 62 arterial thrombosis 62 commercialize deforolimus 62 selective kinase inhibitor 62 antiepileptics 62 metabolite identification 62 nosocomial pneumonia 62 molecular profiling 62 chimeric monoclonal antibody 62 beta interferons 62 specific lectin receptors 62 SomatoKine 62 Cetrorelix 62 synthetic siRNA 62 schizophrenia CIAS 62 Serdolect ® 62 Adentri 62 macrolide antibiotics 62 selective modulator 62 NEUGENE 62 hematological malignancy 62 investigational hepatitis C 62 bardoxolone methyl 62 CRLX# 62 TLR9 agonists 62 dermatological diseases 62 PDX pralatrexate 62 PKC# 62 uric acid lowering 62 HCV protease inhibitor 62 mapatumumab 62 antiangiogenic agents 62 leukotriene receptor antagonist 62 cellular immunotherapy 62 vaccines oncolytic virus 62 Raptiva ® 62 proliferative disorders 62 Ozarelix 62 Soliris TM eculizumab 62 bosutinib 62 telomerase inhibitor 62 photodisinfection 62 Revimmune 62 Gamunex C 62 atypical Hemolytic Uremic Syndrome 62 PDE7 62 #D#C# 62 dacetuzumab 62 refractory Hodgkin lymphoma 62 R#/MEM # 62 paclitaxel poliglumex 62 IgG1 antibody 62 candidate deforolimus 62 Tarvacin TM 62 adjuvant GIST 62 pediatric malignancies 62 Onalta 62 Perforomist ™ Inhalation Solution 62 clinical pharmacology studies 62 Avonex interferon beta 1a 62 mTOR mammalian target 62 gastrointestinal stromal tumors 62 Onco TCS 62 IMiDs R 62 selective immunoproteasome inhibitor 62 biochemical profiling 62 Ceflatonin R 62 calcineurin inhibitors 62 antithrombotic 62 TKI therapy 62 small molecule agonists 62 Vascugel 62 ribonucleotide reductase clinically validated 62 vorinostat 62 receptor inhibitors 62 Rituxan rituximab 62 Listeria vaccine 62 Kamada AAT 62 GVAX ® 62 cathepsin K inhibitor 62 HSP# inhibitors 62 anti infective treatments 62 JAK2 inhibitors 62 hypophosphatasia 62 coagulation disorders 62 HuMax CD4 62 lymphoid tumors 62 resolvins 62 essential thrombocythemia ET 62 phase IIb clinical 62 Cobalamin TM mediated 62 recurrent glioblastoma multiforme 62 subcutaneous formulation 62 WILEX 62 Hemopurifier ® 62 oropharyngeal candidiasis 62 Inhaled nitric oxide 62 recurrent NSCLC 62 TELCYTA TM TLK# 62 Lipsovir ® 62 optimal dosing 62 Hedgehog antagonist 62 Tumour Vascular Disrupting Agent 62 P#X# 62 pathophysiological effects 62 Ataluren 62 oral talactoferrin 62 kinase inhibition 62 Zytiga 62 Ambrisentan 62 PANVAC VF 62 hematologic disorders 62 predictive toxicology 62 MyVax R 62 haematological malignancies 62 therapeutically relevant 62 oxidative stress inducer 62 maximally tolerated dose 62 LY# [003] 62 diagnostic biomarker 62 rilonacept 62 Genz # 62 immuno therapeutic 62 IL# PE 62 CMV vaccine 62 trastuzumab DM1 T DM1 62 Oncaspar 62 Cardiotoxicity 62 oral ridaforolimus 62 TLK# 62 tumor hypoxia 62 K ras mutations 62 mRCC 62 erlotinib Tarceva ® 62 antimetabolite 62 Xcytrin R 62 rALLy 62 Granulocyte Colony Stimulating Factor 62 Cellegesic 62 antiplatelet therapies 62 patented Bioral 62 Bayer Nexavar 62 demethylating agent 62 Nexavar ® 62 BENLYSTA ® 62 radioimmunotherapy RIT 62 Silodosin 62 CXCR4 receptor 62 ISF# 62 Kinoid 62 Aganocide 62 TRIST study 62 L BLP# 62 Fx #A 62 TransVax ™ 62 inhibitor RG# 62 angiogenesis inhibitor 61 Cand5 61 Adnectin 61 Dextofisopam 61 inflammatory autoimmune diseases 61 Arcalyst 61 fibrotic diseases 61 Alzheimer disease cognitive impairment 61 MP4 molecule 61 MDS AML 61 Potelligent Technology 61 Smac mimetic 61 CB2 receptor 61 Preclinical studies suggest 61 PSN# [001] 61 lenalidomide Revlimid R 61 hepatitis C HCV 61 Loramyc R 61 hypervascular tumors 61 IV acetaminophen 61 BLA filing 61 Octreotide 61 INT# [002] 61 Crizotinib 61 Plenaxis TM 61 Monoclonal antibody 61 candidates Azedra TM 61 Nicole Onetto MD 61 XL# XL# 61 Aliskiren 61 Pruvel 61 Phase 2a clinical trials 61 BioNumerik 61 atacicept 61 tumor subtypes 61 biomarker assays 61 solid organ transplantation 61 human alpha interferon 61 SAR# [002] 61 Anticalins R 61 anti thrombotics 61 aflibercept VEGF Trap 61 humanized monoclonal antibody 61 immunomodulator 61 histone methyltransferases HMTs 61 Zavesca